Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2000 Jul 12;55(1):136-9.

    The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study.

    Source

    Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.

    Abstract

    In a double-blind study versus placebo, the serotonergic agent m-chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24 hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT2B,2C,1A receptor subtypes in the pathophysiology of migraine.

    PMID:
    10891925
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk